GlassScriptPhysician profile
Kliti Tane
NPI 1699713214
$2,749.22
in general payments reported to CMS, 2019-2025
20 companies · $841 in 2025
The $841 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $353 · 2020: $90.81 · 2021: $172 · 2022: $546 · 2023: $467 · 2024: $279 · 2025: $841.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,587.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $503.51 | 2024-2025 | Kyphon Express II Kyphopak Tray, Mycarelink |
| Abbott Laboratories | $395.66 | 2022-2025 | Aveir |
| Boston Scientific Corporation | $264.69 | 2023-2025 | Watchman, Watchman Access System |
| Abbvie INC. | $237.65 | 2021-2024 | Avycaz, Dalvance |
| Astrazeneca Pharmaceuticals LP | $228.10 | 2019-2023 | Wainua, Farxiga |
| Protega Pharmaceutials INC | $215.54 | 2025 | Roxybond |
| Janssen Pharmaceuticals, INC | $205.87 | 2019-2023 | Xarelto |
| Medtronic Vascular, INC. | $144.93 | 2019 | |
| Pfizer INC. | $117.35 | 2021-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.80 | 2025 | Lifevest |
| Paratek Pharmaceuticals, INC. | $84.95 | 2022-2023 | Nuzyra |
| E.R. Squibb & Sons, L.L.C. | $44.93 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $34.88 | 2020-2021 | |
| Biotronik INC. | $30.77 | 2020 | |
| Kestra Medical Technology Services, INC. | $30.46 | 2023 | Assure Wcd |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $26.67 | 2022 | |
| Melinta Therapeutics, LLC | $22.61 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $22.60 | 2023 | Inpefa |
| Merck Sharp & Dohme LLC | $18.80 | 2019 | |
| Allergan, INC. | $18.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kliti Tane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.